D-0539-2023 Class II Ongoing

Recalled by Ascend Laboratories, LLC — Parsippany, NJ

FDA drug recall D-0539-2023 was initiated by Ascend Laboratories, LLC on Mar 17, 2023 and is designated Class II. Reason for recall: Out of specification (OOS) for Spectroscopic Identification test by IR. The recall status is ongoing. Affected quantity: 135 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 26, 2023
Initiation Date
Mar 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
135 bottles

Product description

Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05

Reason for recall

Out of specification (OOS) for Spectroscopic Identification test by IR.

Distribution pattern

Nationwide in the USA

Code information

Lot #22143120, Exp. Date: June 2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0539-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0539-2023. Report a data issue: hello@regdatalab.com.